Agilon Health, Inc. (AGL), headquartered in Long Beach, California, is a pioneer in the healthcare industry, offering an innovative platform designed to leverage technology and partnerships to enhance the quality of patient care. The company, which was founded in 2016, is listed on the New York Stock Exchange with significant popularity among investors.
Agilon Health serves independent primary care physicians and senior patients, facilitating a high-performing health system that improves coordination and efficiency in patient care. Their business model revolves around providing technology-enabled services to these physicians, allowing them to transition seamlessly from volume-based to value-based healthcare practices. This move ensures a focus on the overall health outcomes and patient experience rather than simply the number of treatments or service provided, leading to better care for patients and more predictable, stable revenue for physicians.
Agilon's key offering, the agilon health Platform (aHP), is a uniquely robust solution integrating principles of population health management, data analytics, and collaborative care planning. This transformative tool empowers physicians with comprehensive patient data, actionable insights, and the ability to anticipate patients' needs. Through the aHP, Agilon Health actively engages physicians and encourages them to take lead in patients' health management, leading to personalized, effective care strategies and valuable long-term doctor-patient relationships.
Furthermore, Agilon Health has established a model powered by a robust network of primary care physicians. The company has successfully built partnerships with over a dozen physician-centric organizations across the U.S. These collaborations aim to drive a nationwide change in the healthcare industry, fostering a more sustainable, patient-focused approach.
The company’s vision shines through their commitment to support physicians, improve patients' health outcomes, and create a sustainable healthcare ecosystem. Their mission stands on revolutionizing the healthcare model for seniors by enabling physicians to focus on patient care—a vision that Agilon Health seems poised to turn into a reality.
In conclusion, Agilon Health, Inc. is undoubtedly making strides in shifting the healthcare paradigm. By enabling a value-based approach to primary care, equipping physicians with powerful data-drive tools, and fostering strategic partnerships, they are taking the leap forward to redefine and improve the healthcare experience for senior patients across the United States.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
This article highlights several stocks that experienced significant movement yesterday, including Dave & Buster's (PLAY) which fell due to a poor earnings report. In contrast, Vishay Intertechnology (VSH), DocuSign (DOCU), SentinelOne (S), and agilon health (AGL) all saw their stock prices rise following positive analyst coverage, industry recognition, or upgrades. The article provides a brief reason for each company's performance.
Bernstein has upgraded agilon health (AGL) to outperform from market-perform, citing positive results from the company's turnaround efforts. The firm also increased its price target for AGL to $125 from $86, representing a potential 35% upside based on the stock's closing price on September 14. This upgrade signals confidence in the company's recent strategic improvements.
Bernstein has upgraded Agilon Health (AGL) from a "Market Perform" rating to an "Outperform" rating, significantly increasing its price target to $125 from $86. This positive revision reflects a strong analyst confidence in the healthcare company's future performance. The article also mentions recent activities and other analyst adjustments for Agilon Health, including expansions and other rating changes.
Agilon Health (NYSE:AGL) experienced a 5.6% drop in its stock price, trading down to $87.35 with significantly reduced trading volume. Despite beating quarterly earnings and revenue estimates, the company remains unprofitable. Analyst sentiment is mixed, with a consensus "Hold" rating and institutional investors showing varied activity in their holdings.
This article provides analyst ratings and price targets for three healthcare companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING), and Agilon Health (AGL). Eloxx Pharmaceuticals received a Strong Buy consensus with a $40.33 average price target. Cingulate Inc also has a Strong Buy consensus with a $20.25 price target, while Agilon Health has a Hold consensus with a $116.75 average price target.
Truist Securities reiterated a Hold rating on agilon health Inc (NYSE:AGL) with a $112.00 price target, despite the stock currently trading at $95.92. The firm's optimism stems from recent meetings where agilon health management expressed confidence in the company's strong foundation, improved data visibility, and progress in clinical programs and payer relationships. This positive outlook is further supported by the company's extraordinary 881% return over the past six months and a recent beat on second-quarter earnings and revenue expectations.
Truist Securities analyst Jailendra Singh reiterated a Hold rating and an $112.00 price target for agilon health Inc (NYSE: AGL). The article provides this analyst's commentary on the company, titled 'From Stabilization to Value Creation'. Access to the full article requires a StreetInsider.com Premium subscription.
Agilon Health (AGL) reported first-quarter earnings of $1.8 per share, significantly surpassing the Zacks Consensus Estimate of $1.13, and revenues of $1.42 billion, also beating estimates. Despite a decrease in year-over-year revenues, the company has topped consensus revenue estimates in three of the last four quarters. The stock currently holds a Zacks Rank #3 (Hold), indicating it is expected to perform in line with the market.